Skip to main content
. 2023 Mar 21;6(3):e233949. doi: 10.1001/jamanetworkopen.2023.3949

Table 2. Results of Logistic Regression Analyses.

Covariate Answered yes to the following question, OR (95% CI)a
Have you ever heard about HPV? Have you ever received at least 1 HPV vaccine dose? Would you wish to be informed about HPV at your GP’s office, independently of whether you are vaccinated against HPV?
Crude Adjusted Crude Adjusted Crude Adjusted
Female gender 1.91 (1.70-2.15) 1.89 (1.67-2.14) 5.01 (4.31-5.84) 4.74 (4.07-5.53) 0.97 (0.77-1.22) 0.99 (0.78-1.24)
Age (reference: <20 y)
20-25 y 1.86 (1.57-2.22) 2.25 (1.86-2.71) 1.21 (1.01-1.45) 1.55 (1.27-1.88) 1.15 (0.82-1.58) 1.17 (0.84-1.63)
≥ 26 y 3.17 (2.58-3.92) 3.87 (3.08-4.87) 0.93 (0.76-1.15) 1.29 (1.02-1.63) 1.01 (0.69-1.45) 0.97 (0.65-1.43)
Enrolled in health care–related program 2.11 (1.85-2.41) 2.30 (2.00-2.65) 2.33 (2.07-2.62) 2.08 (1.83-2.37) 1.01 (0.81-1.27) 1.05 (0.83-1.33)
Health insurance model (reference: managed care models)
Standard model 1.31 (1.13-1.53) 1.27 (1.08-1.49) 1.40 (1.22-1.61) 1.35 (1.16-1.56) 0.89 (0.69-1.18) 0.87 (0.67-1.14)
Unknown 0.67 (0.58-0.77) 0.81 (0.69-0.95) 0.92 (0.79-1.07) 0.95 (0.81-1.13) 1.02 (0.77-1.37) 0.99 (0.74-1.34)
Mainly lived outside Switzerland at age 11-18 y 1.49 (1.20-1.85) 1.64 (1.30-2.05) 0.68 (0.55-0.83) 0.90 (0.72-1.13) 1.65 (1.06- 2.74) 1.75 (1.08-2.83)

Abbreviations: GP, general practitioner; HPV, human papillomavirus; OR, odds ratio.

a

Results are reported in terms of crude and adjusted ORs with 95% CIs. The denominator population corresponds to all included respondents except those who indicated gender as other, since their rare occurrence would have led to high statistical imbalance (n = 5496; 99.5% of total).